Skip to Content Skip to Search

Norway

Respiratory Sales rep

We have been operating in Norway since 1981. We are committed to making our medicines accessible to as many people living in Norway as possible to help them to do more, feel better and live longer.

We have a broad portfolio of pharmaceuticals and vaccines, and market consumer healthcare products in a number of categories, including respiratory health and oral health care.

In Norway we have approximately 80 employees divided between Pharmaceuticals (medicines and vaccines) and Consumer Healthcare (merchandise and over-the-counter medicines).

We are proud of our employees who, in addition to being dedicated to their job, also show great community involvement with many different causes, such as the environment and working with disadvantaged groups.

 

 

Our Pharmaceuticals

We are Norway's largest supplier of asthma, COPD and HIV medicines and supply a broad portfolio of pharmaceuticals to the Norwegian market. Going forward, GSK will increase its investment in oncology and immunology, and our ambition is to increase the number of clinical studies in Norway in these areas.

Visiting address
GlaxoSmithKline AS
Drammensveien 288
NO-0283 Oslo
Tel: +47 22 70 20 00
Email: no.firmapost@gsk.com
Organisation number: NO 930 606 308

Postal address
GlaxoSmithKline AS
Postboks 180 Vinderen
NO-0319 Oslo

Invoice address
Email: gsk-norway@eportaldoc.com

Medical information
Tel: +47 22 70 20 00 (09.00 to 15.00)
Email: Nordic.medinfo@gsk.com (for HCPs only)

As a pharmaceutical company we cannot give medical advice to patients or dependants. Please contact your GP or local pharmacy.

If you are healthcare personnel and require a scientific discussion with one of our advisors, please call us.  We have medical advisors for respiratory, vaccines, HIV, and oncology.

Media enquiries
Line Storesund Rondan, Head of External Affairs and Market Access
Tel: +47 908 50 492 
We post press releases and other relevant information for journalists on MyNewsdesk. The content of the press service is only intended for journalists and editorial staff. You can also find press releases on our global page.

Our Vaccines

We are currently the largest supplier of vaccines to the Norwegian childhood vaccination programme. Our vaccine portfolio consists of more than 30 different vaccines and prevents diseases such as meningococcal disease, polio, pertussis, tetanus, diphtheria, HPV, hepatitis A/B, rotavirus, measles, rubella and influenza.

Visiting address
GlaxoSmithKline AS
Drammensveien 288
NO-0283 Oslo
Tel: +47 22 70 20 00
Email: no.firmapost@gsk.com
Organisation number: NO 930 606 308

Postal address
GlaxoSmithKline AS
Postboks 180 Vinderen
NO-0319 Oslo

Invoice address
Email: gsk-norway@eportaldoc.com

Medical information
Tel: +47 22 70 20 00
Email: Nordic.medinfo@gsk.com (for HCPs only)
As a pharmaceutical company we cannot give medical advice to patients or dependants. Please contact your GP or local pharmacy.

If you are healthcare personnel and require a scientific discussion with our scientific adviser for vaccines, please call us. You can also get answers to questions about vaccines and vaccinations by contacting the National Institute of Public Health or by checking in the NIPH Vaccination Book (Vaksinasjonsboka). 

Media enquiries
Line Storesund Rondan, Head of External Affairs and Market Access
Tel: +47 908 50 492 
We post press releases and other relevant information for journalists on MyNewsdesk. The content of the press service is only intended for journalists and editorial staff. You can also find press releases on our global page.

Our Consumer Healthcare products

In Norway, GSK Consumer Healthcare markets products in the categories of respiratory health, pain, oral health care, and smoking cessation such as Otrivin, Voltarol, Sensodyne, and Nicotinell.

Visiting address
GlaxoSmithKline Consumer Healthcare Norway AS
Drammensveien 288
NO-0283 Oslo
Tel: +47 22 70 20 00
Email: scanda.consumer-relations@gsk.com

Postal address
GlaxoSmithKline Consumer Healthcare Norway AS
Postboks 180 Vinderen
NO-0319 Oslo

Invoice address
Email: NO.Invoicenorway@gsk.com

Medical information
Tel: +47 22 70 20 00
Email: consumer-relations@gsk.com

Media enquiries
Andreia Cucu, EMEA Drive Profit Communications Director
Tel: +44 7341079647

Reporting an adverse event

Tel: +47 22 70 20 00
Click here to report an adverse event. 

Careers

Search for jobs in Norway

Healthcare professionals

Healthcare professionals in Norway can obtain information about products and areas of therapy related to GSK by visiting GSKPro.no

Collaboration with health professionals and health organisations

The European Federation of Pharmaceutical Industries and Associations (EFPIA), of which the Association of the Pharmaceutical Industry in Norway (LMI) is a member, has been at the forefront of announcing all financial transfers to healthcare professionals since 2015.

From the beginning, GSK has had full transparency about all payments, and we are pleased that LMI and the Norwegian Medical Association have now agreed on this as standard in Norway from 1 June 2020.

Go to the full EFPIA report and read more

Back to top

Collaboration with patient advocacy groups (PAGs)

Patient advocacy groups represent an important partner for GSK. Our goal is to help patients - then we must understand what it is like to live with a disease and what needs the patients have. GSK Norway follows at all times current internal GSK guidelines and ethical rules from the trade association (LMI) for support and collaboration with patient organisations.

Transparency provides the basis for good cooperation. Therefore, every year we publish an overview of the PAGs that GSK has collaborated with. The independence of PAGs is important to us, and we therefore encourage the organisations to have more partners.

See overview of patient advocacy group support from 2018-2020.

Back to top